BIOLASE Receives FDA Clearance for the EPIC 10S Soft Tissue

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BIOLASE Receives FDA Clearance for the EPIC 10S Soft Tissue Diode Laser for a Broad Spectrum of Medical Procedures

IRVINE, CA--(Marketwired - Apr 11, 2013) - BIOLASE, Inc. ( NASDAQ : BIOL ), the world's leading manufacturer and distributor of dental lasers, announced today that the U.S. Food and Drug Administration (FDA) has cleared the EPIC 10S™ soft tissue diode laser for use as a surgical instrument for over 80 different indications in 19 medical markets including: ear, nose and throat, oral surgery, arthroscopy, gastroenterology, orthopedics, general surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology, neurosurgery, ophthalmology, pulmonary surgery, cardiac surgery, thoracic surgery, urology, dermatology, aesthetics, and vascular surgery (see Exhibit A for a detailed listing of medical markets and indications). The EPIC 10S is the surgical model of the recently released, next-generation dental EPIC 10™.

"We are extremely pleased to receive clearance for such a broad number of indications and procedures for our EPIC platform. The clearance for the EPIC 10S is based on the clearance we received in February 2013 for our older Diolase soft tissue diode laser and, needless to say, we are extremely happy to have received it so quickly," said Federico Pignatelli, Chairman and Chief Executive Officer. "This clearance gives us the ability to leverage our EPIC 10™ modular soft tissue diode laser platform and consumable business across a wide range of multi-billion dollar medical markets with appropriate strategic partners or in a direct mode. With the vast number of procedures now available for the EPIC, the opportunities for this new modular platform are tremendous."

BIOLASE's diode lasers are currently used in dentistry for a wide variety of surgical soft tissue procedures as an alternative to invasive and traumatic conventional devices, such as the high-speed drill, scalpel, or electrosurge. The 940nm laser wavelength of the EPIC 10 platform is better absorbed by hemoglobin (Hb) and oxyhemoglobin (HbO 2 ) than other diode laser wavelengths, so it cuts efficiently at low power and with considerably less heat and discomfort, making it an excellent alternative to conventional surgical devices. BIOLASE's EPIC 10 940nm wavelength diode laser uses disposable tips which help reduce the risk of infection and cross contamination and is also FDA cleared for tooth whitening and temporary pain relief.

"It is truly remarkable to see how our core technologies can impact so many other medical fields. Our 940nm diode lasers are excellent alternatives to conventional surgical devices and we have already begun performing clinical studies for a variety of these new applications and some of our early results have been extraordinary," said Fred Furry, Chief Operating Officer and Chief Financial Officer. "Our plan remains to focus on growing our core laser business in the dental market but we will also continue to expand the capabilities, applications, and indications for these core technologies in other medical markets, as well."

Exhibit A - Detailed Listing of Medical Markets and Indications for Use

Ear, Nose and Throat and Oral Surgery: Hemostasis, incision, excision, ablation, and vaporization of tissues from the ear, nose, throat and adjacent areas, including soft tissue in the oral cavity, such as:

  • Removal of benign lesions from ear, nose and throat
  • Excision and vaporization of vocal cord nodules and polyps
  • Incision and excision of carcinoma in-situ
  • Ablation and vaporization of hyperkeratosis
  • Laryngeal papillectomy
  • Excision and vaporization of herpes simplex I and II
  • Neck dissection

Arthroscopy: Hemostasis, incision, excision, vaporization, and ablation of joint tissues during arthroscopic surgery, such as:

  • Menisectomy
  • Syovectomy
  • Chondromalacia

Gastroenterology: Hemostasis, incision, excision, and vaporization of tissue in the upper and lower gastrointestinal tracts via endoscopy, such as:

  • Hemostasis of upper and lower GI bleeding
  • Excision and vaporization of colorectal carcinoma
  • Excision of polyps
  • Hemostasis of colonoscopy
  • Hemostasis of esophageal varices

Orthopedics:

  • Dissect and coagulate

General Surgery, Dermatology & Plastic Surgery, and Podiatry: Excision, ablation, vaporization, and photocoagulation of skin lesions, hemostasis, incision, excision, vaporization, ablation, and debulking of soft tissue, abdominal, rectal, skin, fat or muscle tissue, and dermabrasion, such as:

  • Matrixectomy
  • Excision of neuromas
  • Excision of periungual and subungual warts
  • Excision of plantar warts
  • Excision of Keloids
  • Excision of cutaneous lesions
  • Hemorrhoidectomy
  • Appendectomy
  • Debridement of decubitus ulcer
  • Hepatobiliary
  • Mastectomy
  • Dermabrasion
  • Vaporization & hemostasis of capillary hemangioma
  • Excision, vaporization & hemostasis of abdominal tumors
  • Excision, vaporization & hemostasis of rectal pathology
  • Pilonidal cystectomy
  • Herniorraphy
  • Adhesiolysis
  • Parathyroidectomy
  • Laparoscopic cholecystecomy
  • Thyroidectomy
  • Resection of organs

GI/GU: Excision, vaporization, and hemostasis of abdominal and rectal tissues, such as:

  • Hemorrhoidectomy
  • Excision, vaporization, and hemostasis of rectal pathology
  • Excision, vaporization, and hemostasis of abdominal tumors

Gynecology: Ablation, excision, hemostasis, and vaporization of tissue, such as:

  • Excision or vaporization of condylomata acuminata
  • Vaporization of CIN (cervical intraepithelial neoplasia)
  • Cervical conization
  • Menorrhagia
  • Ovarian cystectomy

Neurosurgery: Vaporization, coagulation, excision, incision, ablation and hemostasis of tissue, such as:

  • Hemostasis in conjunction with meningiomas
  • Percutaneous Disc Decompression (PLDD)

Ophthalmology:

  • Dacryocystorhinostomy transcanalicular
  • Open DCR
  • Tumor Excision
  • Blepharoplasty

Pulmonary Surgery: Hemostasis, vaporization, and excision of tissue, such as:

  • Tracheobronchial malignancy or stricture
  • Benign and malignant pulmonary obstruction

Cardiac Surgery:

  • Coagulation and hemostasis of cardiac tissue

Thoracic Surgery:

  • Thoracotomy
  • Pulmonary resection
  • Hemostasis
  • Pericardiectomy
  • Adhesiolysis
  • Coagulation of blebs and bullae

Urology: Hemostasis, vaporization, incision, coagulation, ablation, and excision of tissues, such as:

  • Vaporization of urethral tumors
  • Release of urethral stricture
  • Removal of bladder neck obstruction
  • Excision and vaporization of condyloma
  • Lesions of external genitalia
  • Circumcision
  • Vaporization of the prostate to treat benign prostate hyperplasia (BPH)

Dermatology/Aesthetics:

  • Photocoagulation of vascular & dermatological lesions of the face and extremities
  • Photocoagulation of telangiectasia, venulectasia of the legs and face
  • Treatment of reticular veins and branch varicosities
  • Pyrogenic granuloma, lymphangioma and lymphangiomatosis disease, angiofibromas
  • Superficial benign vascular lesions including Telangiectasias, hemangioma, Port wine stains, angiokeratoma, and benign epidermal pigment lesions as lentigines, epidermal nevi, spider nevi
  • Dermatological surgery: Condyloma acuminate, warts, small non-malignant skin tumors, small semi-malignant tumors as basaliomas, Bowe and Kaposi sarcoma, warty leucoplasty and ulcers debridement
  • Seborrheic keratosis
  • Mixoid cyst
  • Papillary varix
  • Acne treatment

Vascular Surgery:

  • Photocoagulation of vascular & dermatological lesions of the face and extremities
  • Photocoagulation of telangiectasia, veinulectasia of the legs and face
  • Treatment of reticular veins and branch varicosities

About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment ; products that are focused on technologies that advance the practice of dentistry and medicine . The Company's laser products incorporate over 340 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,000 lasers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com , Facebook at www.facebook.com/biolaseinc , Twitter at twitter.com/biolaseinc , and YouTube at www.youtube.com/biolasevideos .

For further information, please contact: Michael Porter Porter, LeVay & Rose, Inc. 212-564-4700

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 93

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 106

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Rock & Roll Hall of Fame's 2026 Induction Triumph

Updated Category News Views 158

A Night of Unstoppable Talent The Rock & Roll Hall of Fame's 2026 Induction Ceremony and boy, what a spectacle it was. Held on a lively Saturday night, November 14, in Los Angeles, it wasn't just an event; it was an electrifying testament to music's profound impact. With the grand ceremony kicking off at the historic city of stars, this year's induction turned the dial to...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 35

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Thread AI Joins Microsoft Pegasus: Big AI Leap

Updated Category News Views 13

Thread AI Leaps Ahead with Microsoft Partnership There's excitement in the air as Thread AI joins forces with Microsoft by entering the exclusive Pegasus Program. In the ever-evolving world of AI, making a splash this big doesn't happen every day. People in the tech alley are buzzing, and it looks like Thread AI is ready to rumble on a larger stage—much like a scrappy...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 49

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 199

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 118

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 120

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 73

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading

Top 5 Most Recently Viewed Articles

Tevogen Bio Achieves Nasdaq Compliance and Future Prospects

Updated Category News Views 107

Tevogen Bio Regains Compliance with Nasdaq Listing Standards Tevogen Bio Holdings Inc. (NASDAQ: TVGN), a clinical-stage company specializing in immunotherapy, recently made headlines with its announcement of regained compliance with Nasdaq's listing standards. This pivotal moment for Tevogen showcases its dedication to maintaining a strong presence in the biotech...

Continue Reading
aTyr Pharma Investors: Join the Class Action Opportunity

Updated Category News Views 270

Understanding Your Rights as a Shareholder of aTyr Pharma Investors in aTyr Pharma, Inc. (NASDAQ: ATYR) are currently faced with a significant opportunity as a class action lawsuit has been initiated. This legal action is directed towards addressing serious concerns regarding the company's disclosures and conduct during a specific timeframe when many shareholders acquired...

Continue Reading
Chinafy and Lianwei Unite for Enhanced Web Solutions

Updated Category News Views 260

Chinafy and Lianwei Unveil Strategic Collaboration In an exciting development, Chinafy, a renowned cross-border web optimization platform, has announced a strategic partnership with Lianwei, a reputable provider of security and compliance consulting services. This collaboration marks the beginning of a new chapter in ensuring efficient web performance and regulatory...

Continue Reading
Insights on Octopus AIM VCT 2 plc's Current Net Asset Value

Updated Category News Views 107

Understanding the Current Net Asset Value of Octopus AIM VCT 2 plc Octopus AIM VCT 2 plc is a venture capital trust that has recently disclosed some important financial metrics regarding its net asset value (NAV). Knowing the NAV is crucial for investors as it represents the value of the company's assets minus liabilities, particularly helpful for assessing the worth of...

Continue Reading
FTAI Aviation: Unpacking Market Sentiment and Trends

Updated Category News Views 195

Understanding the Current Market Sentiment of FTAI Aviation In the realm of investments, the behavior of high-capital investors, often referred to as "whales," provides insightful indicators of market trends. Recently, these investors have taken a notably bearish stance on FTAI Aviation. Upon analyzing the options trading history for FTAI Aviation, there have been a total...

Continue Reading